884 related articles for article (PubMed ID: 28629171)
1. Cutaneous Manifestations of Human and Murine Leishmaniasis.
Scorza BM; Carvalho EM; Wilson ME
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629171
[TBL] [Abstract][Full Text] [Related]
2. PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.
Zijlstra EE
PLoS Negl Trop Dis; 2014; 8(11):e3258. PubMed ID: 25412435
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Neutrophil Recruitment to the Skin on the Pathology Induced by
Passelli K; Billion O; Tacchini-Cottier F
Front Immunol; 2021; 12():649348. PubMed ID: 33732265
[No Abstract] [Full Text] [Related]
4. Leishmaniasis.
Grevelink SA; Lerner EA
J Am Acad Dermatol; 1996 Feb; 34(2 Pt 1):257-72. PubMed ID: 8642091
[TBL] [Abstract][Full Text] [Related]
5. Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis.
Silveira FT; Lainson R; De Castro Gomes CM; Laurenti MD; Corbett CE
Parasite Immunol; 2009 Aug; 31(8):423-31. PubMed ID: 19646206
[TBL] [Abstract][Full Text] [Related]
6. Tissue damage and immunity in cutaneous leishmaniasis.
Nylén S; Eidsmo L
Parasite Immunol; 2012 Dec; 34(12):551-61. PubMed ID: 23009296
[TBL] [Abstract][Full Text] [Related]
7. The clinical and immunological spectrum of American cutaneous leishmaniasis.
Convit J; Ulrich M; Fernández CT; Tapia FJ; Cáceres-Dittmar G; Castés M; Rondón AJ
Trans R Soc Trop Med Hyg; 1993; 87(4):444-8. PubMed ID: 8249076
[TBL] [Abstract][Full Text] [Related]
8. Endemically exposed asymptomatic individuals show no increase in the specific Leishmania (Viannia) panamensis-Th1 immune response in comparison to patients with localized cutaneous leishmaniasis.
Trujillo CM; Robledo SM; Franco JL; Velez ID; Erb KJ; Patiño PJ
Parasite Immunol; 2002; 24(9-10):455-62. PubMed ID: 12654087
[TBL] [Abstract][Full Text] [Related]
9. Leishmania and HIV co-infection: dermatological manifestations.
Puig L; Pradinaud R
Ann Trop Med Parasitol; 2003 Oct; 97 Suppl 1():107-14. PubMed ID: 14678638
[TBL] [Abstract][Full Text] [Related]
10. Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review.
Silveira FT; Lainson R; Corbett CE
Mem Inst Oswaldo Cruz; 2004 May; 99(3):239-51. PubMed ID: 15273794
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL).
Volpedo G; Pacheco-Fernandez T; Holcomb EA; Cipriano N; Cox B; Satoskar AR
Front Cell Infect Microbiol; 2021; 11():685296. PubMed ID: 34169006
[TBL] [Abstract][Full Text] [Related]
12. Animal model for cutaneous leishmaniasis.
Fischer MR; John D; Kautz-Neu K; Schermann AI; Schwonberg K; von Stebut E
Methods Mol Biol; 2013; 961():389-402. PubMed ID: 23325659
[TBL] [Abstract][Full Text] [Related]
13. Reappraisal of Leishmanin Skin Test (LST) in the management of American Cutaneous Leishmaniasis: A retrospective analysis from a reference center in Argentina.
Krolewiecki AJ; Almazan MC; Quipildor M; Juarez M; Gil JF; Espinosa M; Canabire M; Cajal SP
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005980. PubMed ID: 28981507
[TBL] [Abstract][Full Text] [Related]
14. Improvements in obtaining New World Leishmania sp from mucosal lesions: notes on isolating and stocking parasites.
Dorta ML; Oliveira MA; Fleuri AK; Duarte FB; Pinto SA; Pereira LI; Ribeiro-Dias F
Exp Parasitol; 2012 Oct; 132(2):300-3. PubMed ID: 22728105
[TBL] [Abstract][Full Text] [Related]
15. Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile.
Ismail A; El Hassan AM; Kemp K; Gasim S; Kadaru AE; Moller T; Kharazmi A; Theander TG
J Pathol; 1999 Dec; 189(4):615-22. PubMed ID: 10629566
[TBL] [Abstract][Full Text] [Related]
16. A new scenario in the immunohistochemical diagnosis of cutaneous leishmaniasis.
Fernandez-Flores A
J Cutan Pathol; 2017 Dec; 44(12):1051-1052. PubMed ID: 28990684
[TBL] [Abstract][Full Text] [Related]
17. IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.
Gomes RS; Silva MVT; Dos Santos JC; de Lima Silva LL; Batista AC; Machado JR; Teixeira MM; Dorta ML; de Oliveira MAP; Dinarello CA; Joosten LAB; Ribeiro-Dias F
Parasit Vectors; 2017 Jul; 10(1):336. PubMed ID: 28709468
[TBL] [Abstract][Full Text] [Related]
18. Non-ulcerative cutaneous lesion in immunodeficient mice with Leishmania amazonensis infection.
Terabe M; Kuramochi T; Hatabu T; Ito M; Ueyama Y; Katakura K; Kawazu S; Onodera T; Matsumoto Y
Parasitol Int; 1999 Mar; 48(1):47-53. PubMed ID: 11269325
[TBL] [Abstract][Full Text] [Related]
19. Intermediate/borderline disseminated cutaneous leishmaniasis.
Paniz Mondolfi AE; Duffey GB; Horton LE; Tirado M; Reyes Jaimes O; Perez-Alvarez A; Zerpa O
Int J Dermatol; 2013 Apr; 52(4):446-55. PubMed ID: 23231577
[TBL] [Abstract][Full Text] [Related]
20. Histologic characterization of experimental cutaneous leishmaniasis in mice infected with Leishmania braziliensis in the presence or absence of sand fly vector salivary gland lysate.
Donnelly KB; Lima HC; Titus RG
J Parasitol; 1998 Feb; 84(1):97-103. PubMed ID: 9488345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
